NASOPHARYNGEAL CANCER METASTATIC

NASOPHARYNGEAL CANCER METASTATIC was reported 11 times

NASOPHARYNGEAL CANCER METASTATIC is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 1 0.0000
1 Programmed Death Receptor-1 Blocking Antibody [EPC] 3 0.0000
2 RANK Ligand Inhibitor [EPC] 4 0.0000
3 Acetylcholine Release Inhibitor [EPC] 1 0.0000
4 Fluoroquinolone Antibacterial [EPC] 1 0.0000
5 Leukocyte Growth Factor [EPC] 1 0.0000
6 Microtubule Inhibitor [EPC] 1 0.0000
7 Kinase Inhibitor [EPC] 3 0.0000
8 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
9 Corticosteroid [EPC] 1 0.0000